When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Doxorubicin - Wikipedia

   en.wikipedia.org/wiki/Doxorubicin

   Doxorubicin, sold under the brand name Adriamycin among others, is a chemotherapy medication used to treat cancer. [10] This includes breast cancer , bladder cancer , Kaposi's sarcoma , lymphoma , and acute lymphocytic leukemia . [ 10 ]

3. Alpha-glucosidase inhibitor - Wikipedia

   en.wikipedia.org/wiki/Alpha-glucosidase_inhibitor

   In patients with diabetes mellitus type 1, alpha-glucosidase inhibitors use has not been officially approved by the Food and Drug Administration in the US but some data exists on the effectiveness in this population, showing potential benefits weighted against an increased risk of hypoglycemia. [18]

4. What Are Compounded GLP-1 Medications for Weight Loss? - AOL

   www.aol.com/compounded-glp-1-medications-weight...

   GLP-1s (glucagon-like peptide-1 receptor agonists) are medications used to treat type 2 diabetes and obesity. You’ve probably heard of them under brand names like Ozempi c® and Wegovy ...

5. Anthracycline - Wikipedia

   en.wikipedia.org/wiki/Anthracycline

   Dexrazoxane has also been used with success as a cardioprotective compound in combination with doxorubicin in metastatic breast cancer patients who have been treated with more than 300 mg/m 2 doxorubicin, as well as in patients who are anticipated to have a beneficial effect from high cumulative doses of doxorubicin. [39] [37]

6. GLP-1 receptor agonist - Wikipedia

   en.wikipedia.org/wiki/GLP-1_receptor_agonist

   GLP-1 agonists were initially developed for type 2 diabetes. [7] The 2022 American Diabetes Association (ADA) standards of medical care in diabetes include GLP-1 agonists or SGLT2 inhibitors as a first-line pharmacological therapy for type 2 diabetes in patients who have or are at high risk for atherosclerotic cardiovascular disease or heart ...

7. Diabetes medication - Wikipedia

   en.wikipedia.org/wiki/Diabetes_medication

   Type 2 diabetes is the most common type of diabetes. Treatments include agents that (1) increase the amount of insulin secreted by the pancreas, (2) increase the sensitivity of target organs to insulin, (3) decrease the rate at which glucose is absorbed from the gastrointestinal tract, and (4) increase the loss of glucose through urination.